Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Innovative Precision Medicine Group (IPMG) is a specialized healthcare organization focused on the delivery and implementation of precision medicine solutions in the Middle East and North Africa (MENA) region. The company provides a comprehensive suite of services including advanced genomic testing, molecular diagnostics, and personalized treatment pathways for oncology and rare genetic disorders. IPMG acts as a strategic partner for global biotech and diagnostic firms, facilitating the regional adoption of cutting-edge technologies such as liquid biopsy and comprehensive genomic profiling. Their mission is to bridge the gap between global medical innovations and local patient care through data-driven clinical insights. The group operates as an integrated ecosystem that combines laboratory services, clinical consultation, and digital health solutions to improve patient outcomes.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Innovative Precision Medicine Group.